Debt to Equity
since 2005
Calculation
Abiomed Inc., debt to equity, long-term trends, calculation
| Debt to equity | = | Capital lease obligation1 | ÷ | Stockholders’ equity1 | |
|---|---|---|---|---|---|
| Mar 31, 2022 | 0.00 | = | —) | ÷ | 1,503,326) |
| Mar 31, 2021 | 0.00 | = | —) | ÷ | 1,329,675) |
| Mar 31, 2020 | 0.00 | = | —) | ÷ | 1,065,466) |
| Mar 31, 2019 | 0.00 | = | —) | ÷ | 936,890) |
| Mar 31, 2018 | 0.00 | = | —) | ÷ | 689,524) |
| Mar 31, 2017 | 0.04 | = | 16,338) | ÷ | 452,071) |
| Mar 31, 2016 | 0.00 | = | —) | ÷ | 368,775) |
| Mar 31, 2015 | 0.00 | = | —) | ÷ | 291,560) |
| Mar 31, 2014 | 0.00 | = | —) | ÷ | 168,353) |
| Mar 31, 2013 | 0.00 | = | —) | ÷ | 137,080) |
| Mar 31, 2012 | 0.00 | = | —) | ÷ | 126,297) |
| Mar 31, 2011 | 0.00 | = | —) | ÷ | 104,743) |
| Mar 31, 2010 | 0.00 | = | —) | ÷ | 107,956) |
| Mar 31, 2009 | 0.00 | = | —) | ÷ | 115,983) |
| Mar 31, 2008 | 0.00 | = | —) | ÷ | 93,594) |
| Mar 31, 2007 | 0.00 | = | —) | ÷ | 122,095) |
| Mar 31, 2006 | 0.00 | = | —) | ÷ | 69,488) |
| Mar 31, 2005 | 0.00 | = | —) | ÷ | 56,179) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
- Stockholders’ Equity
- Stockholders' equity exhibited a generally upward trajectory from March 31, 2005, through March 31, 2022. Beginning at $56,179 thousand in 2005, the value increased significantly over the years, reaching $1,503,326 thousand by 2022. Notable dips are observable in 2008 and 2010-2011 periods but were followed by strong recoveries and sustained growth, especially from 2012 onward. The most rapid increase occurred between 2013 and 2019, with equity more than doubling, indicating a period of substantial capital accumulation or retained earnings growth.
- Capital Lease Obligation
- A capital lease obligation is recorded only for the year ending March 31, 2017, with a reported amount of $16,338 thousand. No other years present data for this item, indicating either the initiation or reporting of a lease obligation during this specific period. The absence of data in other years limits trend analysis for this liability.
- Debt to Equity Ratio
- The debt to equity ratio is documented solely for the year ending March 31, 2017, at 0.04. This low ratio reflects minimal leverage relative to equity during that period. The lack of data for other years does not permit evaluation of leverage trends over time; however, the 2017 ratio suggests a conservative capital structure with low financial risk associated with debt financing during that fiscal year.
Comparison to Competitors
Abiomed Inc., debt to equity, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 0.00 | 0.46 | 0.74 | 0.66 | 0.00 | 0.46 | 0.74 |
| Mar 31, 2021 | 0.00 | 0.50 | 0.75 | 0.64 | 0.00 | 0.51 | 0.64 |
| Mar 31, 2020 | 0.00 | 0.57 | 0.93 | 0.60 | 0.00 | 0.49 | 0.66 |
| Mar 31, 2019 | 0.00 | 0.58 | 1.07 | 0.63 | 0.00 | 0.51 | 0.71 |
| Mar 31, 2018 | 0.00 | 0.64 | 1.26 | 0.67 | 0.00 | 0.51 | 0.71 |
| Mar 31, 2017 | 0.04 | 0.90 | 0.72 | 0.75 | 0.00 | 0.66 | 0.66 |
| Mar 31, 2016 | 0.00 | 1.07 | 0.75 | 0.63 | 0.00 | 0.60 | 0.86 |
| Mar 31, 2015 | 0.00 | 0.42 | 0.74 | 0.69 | 0.00 | 0.68 | 0.95 |
| Mar 31, 2014 | 0.00 | 0.36 | 0.34 | 0.62 | 0.00 | 0.61 | 0.54 |
| Mar 31, 2013 | 0.00 | 0.26 | 0.35 | 0.59 | 0.00 | 0.57 | 0.52 |
| Mar 31, 2012 | 0.00 | 0.77 | 0.26 | 0.63 | 0.00 | 0.62 | 0.54 |
| Mar 31, 2011 | 0.00 | 0.63 | 0.26 | 0.42 | 0.00 | 0.62 | 0.41 |
| Mar 31, 2010 | 0.00 | 0.85 | 0.27 | 0.38 | 0.00 | 0.65 | 0.43 |
| Mar 31, 2009 | 0.00 | 0.72 | 0.31 | 0.34 | 0.00 | 0.57 | 0.47 |
| Mar 31, 2008 | 0.00 | 0.65 | 0.34 | 0.41 | 0.00 | 0.60 | 0.62 |
| Mar 31, 2007 | 0.00 | 0.69 | 0.33 | 0.39 | 0.00 | 0.55 | 0.55 |
| Mar 31, 2006 | 0.00 | 0.88 | 0.51 | 0.29 | 0.00 | 0.84 | 0.36 |
| Mar 31, 2005 | 0.00 | 0.46 | 0.26 | 0.27 | 0.00 | 0.23 | 0.40 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., debt to equity, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | 0.00 | 0.61 |
| Mar 31, 2021 | 0.00 | 0.60 |
| Mar 31, 2020 | 0.00 | 0.66 |
| Mar 31, 2019 | 0.00 | 0.71 |
| Mar 31, 2018 | 0.00 | 0.77 |
| Mar 31, 2017 | 0.04 | 0.71 |
| Mar 31, 2016 | 0.00 | 0.73 |
| Mar 31, 2015 | 0.00 | 0.70 |
| Mar 31, 2014 | 0.00 | 0.47 |
| Mar 31, 2013 | 0.00 | 0.44 |
| Mar 31, 2012 | 0.00 | 0.52 |
| Mar 31, 2011 | 0.00 | 0.43 |
| Mar 31, 2010 | 0.00 | 0.46 |
| Mar 31, 2009 | 0.00 | 0.45 |
| Mar 31, 2008 | 0.00 | 0.48 |
| Mar 31, 2007 | 0.00 | 0.47 |
| Mar 31, 2006 | 0.00 | 0.50 |
| Mar 31, 2005 | 0.00 | 0.33 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., debt to equity, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | 0.00 | 0.73 |
| Mar 31, 2021 | 0.00 | 0.79 |
| Mar 31, 2020 | 0.00 | 0.92 |
| Mar 31, 2019 | 0.00 | 0.92 |
| Mar 31, 2018 | 0.00 | 0.86 |
| Mar 31, 2017 | 0.04 | 0.81 |
| Mar 31, 2016 | 0.00 | 0.76 |
| Mar 31, 2015 | 0.00 | 0.69 |
| Mar 31, 2014 | 0.00 | 0.52 |
| Mar 31, 2013 | 0.00 | 0.49 |
| Mar 31, 2012 | 0.00 | 0.51 |
| Mar 31, 2011 | 0.00 | 0.45 |
| Mar 31, 2010 | 0.00 | 0.42 |
| Mar 31, 2009 | 0.00 | 0.41 |
| Mar 31, 2008 | 0.00 | 0.41 |
| Mar 31, 2007 | 0.00 | 0.36 |
| Mar 31, 2006 | 0.00 | 0.33 |
| Mar 31, 2005 | 0.00 | 0.30 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).